Generex Announces Distribution Agreement for Generex Oral-lyn in Chile

16-Sep-2010 - Chile

Generex Biotechnology Corporation announced that it has entered into an exclusive Product Licensing & Distribution Agreement with PMG S.A. (www.pmgpharma.com) for the registration, marketing, distribution and sale of Generex Oral-lyn™, the Company’s proprietary buccal insulin spray product, in Chile.

“We are delighted to have licensed Generex Oral-lyn™ to PMG PHARMA, a well-established company whose principals have a long history in marketing diabetes products,” said Anna Gluskin, Generex’s President & Chief Executive Officer. “This alliance is important as it opens up another key country in South America where diabetes is a highly prevalent condition.”

Other news from the department business & finance

Most read news

More news from our other portals

So close that even
molecules turn red...